We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01403480
Recruitment Status : Completed
First Posted : July 27, 2011
Last Update Posted : July 27, 2011
Information provided by:
Rambam Health Care Campus

Brief Summary:
Basal Cell Carcinoma (BCC) is the most common malignant growth in the world. Treatment is primarily surgical with the goal of excising the growth in its entirety. When pathology results show that this has not been achieved, a re-excision is routinely performed. This study examines retrospectively the percentage of re-excisions of BCC that actually proved to be positive (exhibited growth) among those re-excisions performed at Rambam Healthcare Campus and Zvulun Community Medical Center during the years 2008-10.

Condition or disease
Basal Cell Carcinoma

Study Type : Observational
Estimated Enrollment : 600 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Rates of Positive BCCs in Re-excisions
Study Start Date : January 2008
Primary Completion Date : December 2010
Study Completion Date : February 2011

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All patients that underwent an incomplete BCC excision during the years 2008-2010.

Inclusion Criteria:

All patients that underwent an incomplete BCC excision during the years 2008-2010.

Exclusion Criteria:

Patients that underwent an incomplete BCC excision and were subsequently referred to undergo a MOHS procedure.

Responsible Party: Prof. Yehuda Ullmann, Head, Plastic and Reconstructive Surgery Department, Rambam Healthcare Campus
ClinicalTrials.gov Identifier: NCT01403480     History of Changes
Other Study ID Numbers: 0064-11-RMB-CTIL
First Posted: July 27, 2011    Key Record Dates
Last Update Posted: July 27, 2011
Last Verified: February 2011

Keywords provided by Rambam Health Care Campus:
Basal Cell Carcinoma

Additional relevant MeSH terms:
Carcinoma, Basal Cell
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms, Basal Cell